HomeCompareMEIYF vs PFE

MEIYF vs PFE: Dividend Comparison 2026

MEIYF yields 8.51% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEIYF wins by $868.48M in total portfolio value
10 years
MEIYF
MEIYF
● Live price
8.51%
Share price
$13.76
Annual div
$1.17
5Y div CAGR
76.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$868.53M
Annual income
$804,738,497.33
Full MEIYF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — MEIYF vs PFE

📍 MEIYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEIYFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEIYF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MEIYF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEIYF
Annual income on $10K today (after 15% tax)
$723.10/yr
After 10yr DRIP, annual income (after tax)
$684,027,722.73/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, MEIYF beats the other by $684,005,402.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEIYF + PFE for your $10,000?

MEIYF: 50%PFE: 50%
100% PFE50/50100% MEIYF
Portfolio after 10yr
$434.29M
Annual income
$402,382,378.03/yr
Blended yield
92.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

MEIYF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
0.9
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEIYF buys
0
PFE buys
0
No recent congressional trades found for MEIYF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEIYFPFE
Forward yield8.51%6.13%
Annual dividend / share$1.17$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR76.4%13.2%
Portfolio after 10y$868.53M$49.6K
Annual income after 10y$804,738,497.33$26,258.71
Total dividends collected$863.78M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: MEIYF vs PFE ($10,000, DRIP)

YearMEIYF PortfolioMEIYF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$12,201$1,500.64$9,153$693.39+$3.0KMEIYF
2$16,073$3,018.37$8,593$849.25+$7.5KMEIYF
3$23,754$6,555.47$8,336$1,066.78+$15.4KMEIYF
4$41,388$15,971.67$8,437$1,384.80+$33.0KMEIYF
5$90,164$45,878.60$9,013$1,875.40+$81.2KMEIYF
6$261,247$164,771.55$10,306$2,680.72+$250.9KMEIYF
7$1,066,608$787,074.25$12,820$4,101.38+$1.05MMEIYF
8$6,438,935$5,297,664.23$17,673$6,826.70+$6.42MMEIYF
9$59,613,653$52,723,992.72$27,543$12,591.86+$59.59MMEIYF
10$868,525,106$804,738,497.33$49,560$26,258.71+$868.48MMEIYF

MEIYF vs PFE: Complete Analysis 2026

MEIYFStock

Mercialys is one of France's leading real estate companies, focused exclusively on shopping centers and high-street retail assets. At June 30, 2020, Mercialys had a portfolio of 2,111 leases, representing a rental value of Euro 182.3 million on an annualized basis. At June 30, 2020, it owned properties with an estimated value of Euro 3.5 billion (including transfer taxes). Mercialys has had "SIIC" real estate investment trust (REIT) tax status since November 1, 2005 and has been listed on Euronext Paris Compartment A (ticker: MERY) since its initial public offering on October 12, 2005. At June 30, 2020, there were 92,049,169 shares outstanding.

Full MEIYF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this MEIYF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEIYF vs SCHDMEIYF vs JEPIMEIYF vs OMEIYF vs KOMEIYF vs MAINMEIYF vs JNJMEIYF vs MRKMEIYF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.